OmniSYS and Comprehensive Pharmacy Services Partner to Support Hospital Outpatient Pharmacy Market
April 17, 2018 – OmniSYS, a leading healthcare technology company focused on revenue cycle and patient engagement solutions for pharmacies and pharmaceutical manufacturers, today announced a strategic partnership with Comprehensive Pharmacy Services (CPS), the nation’s largest provider of pharmacy support services to hospital and healthcare facility pharmacies.
OmniSYS and Scientific Technologies Corporation Announce Strategic Partnership
April 4, 2018 – OmniSYS, a leading healthcare technology company focused on revenue cycle and patient engagement solutions for pharmacies and pharmaceutical manufacturers, today announced a strategic partnership with Scientific Technologies Corporation (STC).
OmniSYS Announces Strategic Partnership with PerceptiMed
November 7, 2017– OmniSYS today announced a formal partnership agreement with PerceptiMed through the OmniCONNECT Partner Program. PerceptiMed provides pharmacy automation solutions for prescription verification, dispensing and will-call retrieval.
OmniSYS Acquires Leading Pharmacy Technology Provider
March 1, 2017– OmniSYS, the nationally recognized leader in medical claim billing, Medicare compliance and patient engagement solutions for pharmacies, HME/DME providers and pharmaceutical manufacturers, announced today that it has acquired voiceTech—a leading technology provider to the pharmacy industry.
OmniSYS Appoints New CTO
September 21, 2016– Chris Harding joins healthcare technology leader OmniSYS, a leading provider of billing, compliance, and patient engagement solutions for pharmacies, pharmaceutical manufactures and medical equipment suppliers, announced the company has hired a new executive to help guide the company’s technology transformation.
OmniSYS Appoints New SVP
March 16, 2016 – OmniSYS, LLC, a leading provider of billing, compliance, and patient adherence solutions for pharmacies and medical equipment suppliers, announced today that Dean Braun is joining the company as senior vice president of business development and marketing.are facility pharmacies.
OmniSYS Names New CEO
September 14, 2015 – OmniSYS, LLC, a leading provider of billing, compliance, and patient adherence solutions for pharmacies and medical equipment suppliers, announced today that John G. King is joining the company as chief executive officer, effective September 21, 2015. King, who previously served as president of Standard Register’s healthcare business, replaces interim chief executive officer Andy Kieffer, who will continue to serve on the OmniSYS Board of Directors. pharmacies.
“There is one public health initiative in particular where I believe forward-thinking pharmacies can leverage patient relationships and access to make a significant impact: adult immunization rates… Most adults know they need an annual flu shot. But what about the two-dose pneumococcal vaccine regimen? Or the new shingles vaccination? A significant opportunity exists to educate patients about necessary immunizations, and the pharmacy is in a perfect position to take advantage of this opportunity.”
ComputerTalk l Improving Adult Immunization Rates: Empowering Pharmacies and Patients with Information by John King
“Every year, millions of adults are hospitalized and thousands of adults die from vaccine-preventable diseases. Improving immunization rates is a critical public health issue, and it begins with helping patients understand which vaccinations they need in order to be immunized from life-threatening diseases.”
“Patient communications is the most important market opportunity for pharmacies in 2018…The pharmacy needs to position itself as a health hub for the community, developing strategic, long-term relationships with patients that won’t be disrupted by other market factors.”
“Smart clinical messaging has emerged as a promising technology to facilitate the time-sensitive and accuracy-dependent process of determining vaccine eligibility in the pharmacy…The result is patient- and vaccine-specific alerts that manifest in the pharmacist’s existing workflow in real-time, allowing vaccination opportunities to be addressed at the point of service.”
Effective January 1, 2017, CMS payment for external infusion drugs furnished through a covered item of DME will be based on Section 1847A of the Social Security Act. This means that most of the payments will be based on the Average Sales Price of these drugs.
Adult flu and pneumococcal vaccination rates remain stubbornly low, and the reasons why vary. Misinformation and indifference are common reasons for low adult vaccination rates, despite universal recommendations by public health officials.
CMS has announced the new single payment amounts and began sending contract offers to successful bidders for Medicare’s Round 2 Recompete and the national mail-order recompete DMEPOS Competitive Bidding Program.